Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.26% Nasdaq Down0.42%

Biogen Idec Inc. (BIIB)

-NasdaqGS

152.53 Down 0.04(0.03%) Oct 5, 4:00PM EDT|After Hours : 153.41 Up 0.88 (0.58%) Oct 5, 4:46PM EDT

Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 29, 2012Mar 30, 2012Dec 30, 2011Sep 29, 2011
Total Revenue 1,420,952   1,292,014   1,326,710   1,309,934  
Cost of Revenue139,111  133,197  139,637  123,527  
Gross Profit 1,281,841   1,158,817   1,187,073   1,186,407  
Operating Expenses
Research Development329,559  355,962  338,934  301,391  
Selling General and Administrative393,138  387,241  387,533  345,373  
Non Recurring1,139  283  636  1,803  
Others52,282  45,961  50,867  49,347  
Total Operating Expenses776,118  789,447  777,970  697,914  
Operating Income or Loss 505,723   369,370   409,103   488,493  
Income from Continuing Operations
Total Other Income/Expenses Net -  15,144  (3,973) -  
Earnings Before Interest And Taxes508,673  384,514  405,130  480,766  
Interest Expense -   -   -   -  
Income Before Tax508,673  384,514  405,130  480,766  
Income Tax Expense121,021  82,148  104,920  127,104  
Minority Interest(295)295  28  (1,836)
Net Income From Continuing Ops386,846  302,661  300,238  351,826  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 386,846   302,661   300,238   351,826  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 386,846   302,661   300,238   351,826  

Currency in USD.